Breaking News

AAOS: FDA Clears DJO Global's Exprt Revision Hip

By Business Wire | March 15, 2017

Surgeons have the opportunity to preview the full-line, modular femoral stem at the AAOS annual meeting.

DJO Global Inc., a global provider of medical technologies designed to get and keep people moving, announced that its Exprt Revision Hip portfolio received market clearance by the U.S. Food and Drug Administration. Exprt Revision Hip is the latest addition to DJO Global’s Exprt portfolio—a platform defying conventional approaches to total joint implants by improving outdated designs, focusing on patient outcomes and reinventing traditional price points.
 
The 12,000 surgeons expected to attend this year’s Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS booth #1733) in San Diego, Calif. will have an opportunity to preview the full-line, modular femoral stem inspired by the clinical success of Wagner-style predecessors. The system’s intuitive design and premium quality is based on extensive research and development that redefines revision total hip arthroplasty by offering an anatomically inspired design that has an emphasis on efficiency and strength—all for 40-70 percent of the price of comparable revision hip systems.
 
“One of the biggest challenges our healthcare system encounters is introducing modern technologies at increased price points. The latest addition to the Exprt portfolio signifies our deep commitment to not only clinical outcomes, but both surgical and cost efficiencies,” said Mark Russell, senior vice president of the Surgical division of DJO Global.
 
The two-tray revision system represents an 80-90 percent reduction in instruments compared to competitive systems. Streamlined instrumentation translates into less money and time spent on sterilization, less overall time in the operating suite, and less storage space – appropriate for both hospital and ASC settings.
 
Exprt Revision Hip was developed in partnership with industry leading physicians. Michael Taunton, M.D. at the Mayo Clinic and design team member of the Exprt Platform was one of the first surgeons to implant the device. “Having a thoughtful approach to introducing new technology in today’s healthcare landscape will drive shifts in the market place. We designed DJO Global’s Exprt Revision Hip and Knee Systems to challenge conventional approaches to revision arthroplasty. These systems allow me to do what I used to think wasn’t possible—treat my patients with a high-quality implant with improved surgical efficiency and reproducible outcomes while simultaneously being economically responsible.”